Curewell Capital has acquired Wilmington PharmaTech (WPT), according to a news release.
WPT, founded in 2003 and based in Newark, Delaware, is a contract research, development and manufacturing organization focused on custom small molecule API development and manufacturing.
Curewell, founded in 2021 and based in Los Angeles, is a middle market private equity firm focused on healthcare companies headquartered in North America. Within healthcare, the firm targets healthcare services, pharmaceutical services, medical devices and healthcare technology.
Terms of the transaction were not disclosed.
